1 |
Xie J, Yang Y, Gao Y, He J. Cuproptosis: mechanisms and links with cancers. Mol Cancer 2023;22:46. [PMID: 36882769 DOI: 10.1186/s12943-023-01732-y] [Reference Citation Analysis]
|
2 |
Zhang B, Zhang T, Zheng Z, Lin Z, Wang Q, Zheng D, Chen Z, Ma Y. Development and validation of a cuproptosis-associated prognostic model for diffuse large B-cell lymphoma. Front Oncol 2022;12:1020566. [PMID: 36713586 DOI: 10.3389/fonc.2022.1020566] [Reference Citation Analysis]
|
3 |
Zhang B, Xie L, Liu J, Liu A, He M. Construction and validation of a cuproptosis-related prognostic model for glioblastoma. Front Immunol 2023;14:1082974. [PMID: 36814929 DOI: 10.3389/fimmu.2023.1082974] [Reference Citation Analysis]
|
4 |
Liu H, Tao T. Prognosis and immune features of pyroptosis-related RNA patterns in low-grade glioma. Front Oncol 2022;12:1015850. [PMID: 36605437 DOI: 10.3389/fonc.2022.1015850] [Reference Citation Analysis]
|
5 |
Zhu H, Wan Q, Tan J, Ouyang H, Pan X, Li M, Zhao Y. A novel prognostic signature of cuproptosis-related genes and the prognostic value of FDX1 in gliomas. Front Genet 2022;13:992995. [PMID: 36579333 DOI: 10.3389/fgene.2022.992995] [Reference Citation Analysis]
|
6 |
He Y, Cai Y, Liu J, Ding H, Li X, Tian S, Li Z. Systematic Analysis of a Pyroptosis-Related Signature to Predict the Prognosis and Immune Microenvironment of Lower-Grade Glioma. Cells 2022;11. [PMID: 36552744 DOI: 10.3390/cells11243980] [Reference Citation Analysis]
|
7 |
Zhang Z, Wang B, Xu X, Xin T. Cuproptosis-related gene signature stratifies lower-grade glioma patients and predicts immune characteristics. Front Genet 2022;13. [DOI: 10.3389/fgene.2022.1036460] [Reference Citation Analysis]
|